LEADER 01324nam  2200373Ia 450 
001 9910699359903321
005 20230902161549.0
035   $a(CKB)5470000002402316
035   $a(OCoLC)501947533
035   $a(EXLCZ)995470000002402316
100   $a20100126d2000      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $ePET drug applications : content and format for NDAs and ANDAs, fludeoxyglucose F 18 injection, ammonia N 13 injection, sodium fluoride F 18 injection
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[2000]
215   $a1 online resource (41 pages)
300   $a"Draft guidance."
300   $a"Procedural."
300   $a"March 2000."
517   $aGuidance for industry 
606   $aTomography, Emission$zUnited States
606   $aDrug approval$zUnited States
615  0$aTomography, Emission
615  0$aDrug approval
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699359903321
996   $aGuidance for industry$93434577
997   $aUNINA